Program

The XVI NMRM program is under construction.

Check the complete program soon here

Speakers

Nísia Trindade Lima
PRESIDENTE DA FIOCRUZ
Diseases and neglected populations: challenges for Science and Health
Cláudio Tadeu Daniel-Ribeiro
IOC-Fiocruz, rio de janeiro, RJ
Zoonotic malaria in the Brazilian Atlantic forest
Adrian Hill
Oxford Univ, UK
"A low cost, high efficacy and globally distributed COVID-19 vaccine" and "A high efficacy malaria vaccine with large scale supply"
Anthony Fauci
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIAID-NIH, ROCKVILLE, MD, EUA
COVID-19: Lessons learned and remaining challenges
Pedro L. Alonso
DIRETOR, GLOBAL MALARIA PROGRAMME - OMS, Genebra, suiça
Global Malaria Programme: where are we?
Hans Ackerman
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIAID-NIH, ROCKVILLE, MD, EUA
Sickle cell disease: malaria's deadly legacy
Marco Aurélio Krieger
VICE-PRESIDENTE DE PRODUÇÃO E INOVAÇÃO DA FIOCRUZ, RIO DE JANEIRO,RJ
The Covid-19 vaccine in Fiocruz
Richard Culleton
EHIME UNIVERSITY, JAPAN
The evolutionary history of zoonotic malaria
Cristiana F. Alves de Brito
IRR-FIOCRUZ, BELO HORIZONTE, MG
Plasmodium spp. infection in non-human primates in the Atlantic Forest
Michael Theisen
STATENS SERUM INSTITUT, COPENHAGUE, DINAMARCA
The Pfs48/45 transmission blocking vaccine
Daniel Bargieri
UNIVERSIDADE DE SÃO PAULO, SP
Compounds with transmission-blocking activity
Daniel Antunes Villela
PROCC, FIOCRUZ, RJ
Statistical analysis and models of recurrences of Plasmodium vivax malaria in the Brazilian Amazon
Marcus Vinicius Guimarães de Lacerda
ILMD-Fiocruz, Manaus, AM
Malaria in Brazil: are we innovating?
Marcelo Urbano Ferreira
UNIVERSIDADE DE SÃO PAULO, SP
Urbanization and malaria in the Brazilian Amazon
Wuelton Marcelo Monteiro
FUNDAÇÃO DE MEDICINA TROPICAL DR. HEITOR VIEIRA DOURADO, MANAUS, AM
G6PD deficiency and safety of hypnozoiticide drugs
Fábio Trindade Maranhão Costa
UNIVERSIDADE DE CAMPINAS,  SP
Discovering new molecular targets against Plasmodium vivax
Marcelo Yoshito Wada
CGZV-DEIDT-SVS-MS, BRASÍLIA, DF
Overview of the malaria research supported by the Ministry of Health
Dave Richard
UNIVERSITÉ LAVAL, QUÉBEC, CANADÁ
Exploring the roles of phosphoinositides in the erythrocytic cycle of Plasmodium falciparum
Georges Snounou
INSTITUT DE BIOLOGIE FRANÇOIS JACOB, CEA, PARIS, FRANÇA
Of apes, monkeys, and their contribution to malaria
Clemens Kocken
BIOMEDICAL PRIMATE RESEARCH CENTER, RIJSWIJK, HOLANDA
Plasmodium cynomolgi as a model to tackle malaria dormancy
Shigeyuki Kano
NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE, TOKYO, JAPÃO
New technologies and strategies to ultimately eliminate malaria
Didier Menard
Institut Pasteur, Paris, França
Artemisinin resistance in Africa: Where, when and how?
Hernando del Portillo
ISGLOBAL, BARCELONA, ESPANHA
Cryptic erythrocytic infections in Plasmodium vivax
Célia Garcia
USP, São Paulo, SP
Cellular signaling in host-Plasmodium interactions
Maria de la Paz Ade y Torrent
OPAS, WASHINGTON, DC, EUA
The need to improve/implement a quality assurance system for malaria diagnosis moving towards elimination
Beatriz Grinsztejn
INI-FIOCRUZ, Rio de Janeiro, RJ
Brazil-US collaborative research on HIV
Rafael Maciel de Freitas
IOC-Fiocruz, rio de janeiro, RJ
Wolbachia as a tool for arbovirus control
Giselle Rachid Viana
INSTITUTO EVANDRO CHAGAS, BELÉM, PA
Deletion of pfhrp2 and pfhrp3 in the Brazilian Amazon Basin
Ricardo T. Gazzinelli
IRR-FIOCRUZ, Belo Horizonte, MG
Immunometabolism in malaria
Georges E. Grau
UNIV OF SIDNEY, AUSTRALIA
Cellular and extracellular elements in cerebral malaria pathogenesis
Matthias Marti
UNIVersity of GLASGOW, ESCÓCIA
Parasite infection in the hematopoietic niche: an emerging paradigm in malaria research
Joana Carneiro da Silva
UNIV OF MARYLAND, BALTIMORE, EUA
Plasmodium targets of host immune response to malaria immunization and natural infection
André Siqueira
INI-FIOCRUZ, Rio de Janeiro, RJ
Deciphering the contribution of distinct factors to malaria treatment failure
Audrey Lenhart
CDC, ATLANTA, EUA
Malaria vector control innovations: Will they be enough to achieve elimination in the Americas?
Maisa da Silva Araújo
FIOCRUZ-RO, PORTO VELHO
Breeding and Experimental Plasmodium vivax Infection in Brazilian Amazon vectors
Stefanie C. P. Lopes
ILMD-Fiocruz, Manaus, AM
A platform for P. vivax hypnozoite studies in Manaus
Maria Anice Sallum
USP, São Paulo, SP
Deforestation and impact on malaria vectors
José Bento Pereira Lima
IOC-Fiocruz, rio de janeiro, RJ
Vector control and insecticide resistance
Ester Sabino
USP, São Paulo, SP
The sickle cell disease: achievements of the NHLBI/REDS program in Brazil
Caroline Junqueira
IRR-FIOCRUZ, BELO HORIZONTE, MG
CD8+ and Gamma-delta T cells and immunity in malaria
Roberto Moraes Barros
Unifesp, São Paulo, SP
Using Plasmodium knowlesi for in vitro malaria studies
Ric Price
Charles Darwin Univ, Darwin, Australia
Challenges and Opportunities to eliminate P. vivax in the Asia Pacific Region
Sheila Rodovalho
OPAS, Brasília-DF
Impact of Covid-19 on malaria research
Gisely Cardoso Melo
FMT-HVD, Manaus, AM
Ultra-Sensitive qPCR technique to detect early recurrences of Plasmodium vivax
Peter Crompton
NIAID-NIH, Bethesda, MD, EUA
Safety and efficacy of monoclonal antibodies against Plasmodium falciparum malaria in Africa
Claudia Codeço
ENSP-Fiocruz, RJ
Malaria along techno-productive trajectories in the Brazilian Western Amazon
Camila Coelho
LJI, California
SARS-CoV-2- specific memory B cell responses to different vaccine platforms
Olindo Assis Martins Filho
IRR-Fiocruz, Belo Horizonte, MG
Serum soluble mediators as prognostic biomarkers for patients with Yellow Fever
Celina Turchi Martelli
IAM-Fiocruz, PE
The intersection of two pandemics, Zika and COVID-19, in Brazil
Joyce Pereira
CGZV-DEIDT-SVS-MS, Brasília, DF
Advances and perspectives of entomology and malaria vector control in Brazil
Paola Marchesini
CGZV-DEIDT-SVS-MS, Brasília, DF
Perspectives for malaria elimination in Brazil
Filomeno Fortes
Univ Nova de Lisboa, Portugal
Perspectives for malaria elimination in Angola
Nubia Boechat
Farmanguinhos, Fiocruz, Rio de Janeiro
Molecular hybridization in the search for new antimalarials
Marcelo Addas-Carvalho
Unicamp, SP
Transfusional malaria: a Brazilian strategy for risk reduction
Anna Rosanas-Urgell
ITM-Antwerpen, Bélgica
Omics in Plasmodium biology and pathogenesis
Michel Nussenzweig
Rockefeller Univ, New York
Human immune responses to SARS-CoV-2 infection and vaccination
Vincent Munster
Rocky Mountain Labs, NIAID-NIH, Hamilton, MT
Mucosal immunity to coronavirus
Jesus Valenzuela
LMVR, NIAID-NIH, Rockville, MD
Vaccines against vector salivary antigens
Jessica Manning
LMVR, NIAID-NIH, Rockville, MD
Dengue epidemic in Cambodia
Vikrant Sahasrabuddhe
Director, DCP, NCI-NIH, Bethesda, MD
HIV and papiloma virus coinfection
Carolina Barillas-Mury
LMVR, NIAID-NIH, Rockville, MD
New World malaria vectors
Niraj Tolia
LMIV, NIAID-NIH, Bethesda, MD
Structural vaccinology for malaria and COVID-19
Thomas Wellems
Director, LMVR, NIAID-NIH
Vivax malaria drug treatment and genetics of resistance

SATELLITE EVENTS

Emerging and Persistent Global Health Threats

The symposium will take place in Rio de Janeiro in October 2020 with the aim of bringing together NIH and/or NIH funded investigators and students, Brazilian investigators and students with links to NIH (previous or current) and Brazilian investigators in general with an interest in collaborating with NIH and/or with NIH funded laboratories.

See more